Articles On Creso Pharma (ASX:CPH)

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.65% to 6,731.2 points. Four shares that are climbing more than most today are listed below....

Creso Pharma Limited (ASX:CPH; FRA: 1X8) continues to build on a fortnight of strong news flow with its wholly-owned Canadian subsidiary, Mernova Medicinal Inc. receiving three purchase orders with a combined value of C$275,023 (A$288,159)....

On Tuesday the Australian share market continued its positive run and climbed higher again. This led to the market reaching a nine-month high. While this is a big positive, some ASX shares are performing even better. For example, three ASX...

Do you remember what I told you last Tuesday? Well done if so. Personally, I can barely recall what I had for breakfast this morning! Here’s a refresher… I said watch cannabis stocks — the other ‘green’ revolution happening now. A week can...

–The below is a company-sponsored announcement– Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvest...

The emerging cannabis industry has received another vote of confidence, after the United States House of Representatives passed a historic bill to end a federal ban on marijuana last Friday. The proposal has yet to be signed into law. Howe...

Special Report: Australian cannabis company Creso Pharma (ASX:CPH) is lauding a historic vote in the US House of Representatives to ... Read More The post Creso Pharma hails US House vote to decriminalise cannabis at federal level appeared...

The move is expected to have a substantial impact on the company’s global footprint.

Creso Pharma Limited (ASX:CPH; FRA: 1X8) has advised that the US House of Representatives has passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act. The historic bil...

Special Report: The managing director of Creso Pharma’s (ASX:CPH) Canadian subsidiary is making progress promoting recreational cannabis in a market ... Read More The post Creso Pharma’s secret weapon is a cannabis veteran who knows what ca...

The Creso Pharma Ltd (ASX: CPH) share price has been rocketing higher over the last few days of trading, driven by positive updates. These included an announcement yesterday that the United Nations (UN) will reclassify cannabis as a less d...

The Elixinol Global Ltd (ASX: EXL) share price tumbled after management issued an update to its share purchase plan (SPP) today. The EXL share price lost 7.6% to 24 cents in after lunch trade when the S&P/ASX 200 Index (Index:^AXJO) ga...

–The below is a company-sponsored announcement– Creso Pharma Limited ((CPH)); (FRA: 1X8) has had a promising week following positive regulatory changes by both the United Nations Commission on Narcotic Drugs and the Court of Justice of th...

Tiny pot stock Creso Pharma Ltd [ASX:CPH] is soaring today. The CPH share price is trading 22.22% higher at time of writing. A huge boost for investors as the market eyes up this fascinating stock.... The post Creso Pharma Shares Up 20% as...

In a week that has been dominated by extremely positive regulatory news along with highly promising company-specific developments, Creso Pharma Limited (ASX:CPH; FRA: 1X8) has been greeted with a welcome decision by the United Nations Commi...

Summary Creso Pharma revealed that UN nation has decided to reclassify cannabis as a less dangerous drug. The new cannabis ruling is anticipated to unlock several near-term opportunities for the Company. The new classification indicat...

The decision, in essence, recognises the potential medical properties of cannabis and paves the way for the relaxing of cannabis classifications in large markets across the world.

Summary Creso Pharma has received three purchase order worth A$414k for anibidiol® products, bringing the total purchase order generated by animal health segment in 2020 to ~A$975k. The current orders would be shipped to the commercial...

Over recent days, Creso Pharma (ASX: CPH) has rapidly moved from 3c to 5c on strong volumes and it appears to have some significant momentum including three new purchase orders for Creso Pharma’s anibidiol® line of animal health products we...

The new orders take the total purchase orders generated through Creso Pharma’s animal health segment to around A$975,000 for 2020, outlining the strong demand for its industry-leading products.

Shares in Creso Pharma Limited (ASX: CPH; FRA: 1X8) have been on a tear in the last week as the company has unveiled a number of promising developments that will materially impact the group’s earnings. The most recent of these occurred toda...

Special Report: Creso Pharma (ASX:CPH) has received three new purchase orders for its anibidiol line of hemp oil animal health ... Read More The post Creso Pharma picking up steam with more orders for hemp oil pet products appeared first on...

ASX-listed Creso Pharma Limited (ASX:CPH) seems to be in high spirits after an encouraging update on the position of cannabidiol (CBD) products in Europe. The ruling by the highest European court is expected to create a slew of opportunitie...

Special Report: Creso Pharma (ASX:CPH) says a decision by European’s highest court that CBD can be freely sold in the ... Read More The post Creso Pharma seeks to capitalise on European court ruling on CBD – ‘not narcotic’ appeared first on...

The landmark ruling is a major development and provides considerable opportunities for Creso Pharma which has commercial agreements in place in the Iberian markets.

Creso Pharma Limited (ASX:CPH, FRA:1X8) has provided a promising update regarding the status of cannabidiol (CBD) products in Europe. On 19 November 2020, the Court of Justice of the European Union (CJEU) ruled that member states must not p...

Summary TGA’s final decision regarding a significant regulatory change for CBD products distribution in Australia is anticipated in December 2020. Down-scheduling CBD products could lead to substantial market opportunities for Creso Ph...

Special Report: Creso Pharma (ASX:CPH) says if the down-scheduling of cannabidiol goes ahead in December it would unlock a major ... Read More The post Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma appeared first o...

The Therapeutic Goods Administration (TGA) will shortly bring down its final decision regarding a major regulatory change in the distribution of cannabidiol (CBD) products in Australia. The final decision is expected to be delivered in late...

The potential down scheduling of CBD products in Australia unlocks a major market for Creso Pharma’s CBD and hemp products.

Creso Pharma Limited’s (ASX:CPH; FRA: 1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc. a licensed producer in Nova Scotia, has received and successfully delivered its third purchase order (PO) from the Nova Scotia Liquor Corpor...

The order is the third from NSLC in the last four weeks, with the two previous orders for its premium strains, continuing to sell well.

The company is experiencing a strong growth trajectory driven by a strong sales pipeline and growing market demand for its premium products.

Recent data from Israeli Medical Cannabis Agency and Ministry of Health highlights significant market opportunity in the country.

–The below is a company-sponsored announcement– Though it has had its issues over the past 12 months following the failed A$122M acquisition by TSX listed cannabis company PhamaCielo, Creso Pharma ((CPH)) may be turning the corner. After...

Creso Pharma Limited (ASX:CPH, FRA: 1X8) has once again strengthened its revenue profile with another repeat purchase order from South African-based Pharma Dynamics. Creso’s repeat purchase orders now total more than $2 million on a year-to...

While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company...

Special Report: Another order for cannabis lozenges shows the potential of the South African market for Creso Pharma. Creso Pharma ... Read More The post Creso Pharma has now taken $630,000 in orders from South Africa for cannabis lozenges...

The order for cannaQIX® product is being sold under the Cannamics brand in South Africa and follows its successful launch in March 2020.

Summary Creso Pharma secured firm commitments to raise up to ~A$9 million from institutional, professional, as well as sophisticated investors. The funds shall be used for development and accelerating growth across its existing animal a...

Special Report: The Canadian subsidiary of Creso Pharma (ASX:CPH) has received a second order for recreational marijuana after strong sales ... Read More The post Creso Pharma gains momentum with another big cannabis order in Nova Scotia ap...

Mernova’s Ritual Green products are being sold to consumers through NSLC, which is operated by the Nova Scotia provincial government and is the sole distributor of retail recreational cannabis in the region.

The company is now well-placed to accelerate growth in the near-term as well as to reduce debt.

Creso Pharma (ASX: CPH) has appointed Bruce Linton (pictured), industry pioneer and founder of Canopy Growth Corporation (TSE: WEED), to the role of strategic advisor as the medicinal cannabis developer raises nearly $9 million. The appoi...

Developer of cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products Creso Pharma Ltd (ASX:CPH) has secured firm commitments from institutional, professional and sophisticated investors to raise up to $8.992 million (be...

“We anticipate that his appointment will greatly assist us in achieving our near-term operational milestones and longer-term goals,” says CEO Miri Halperin Wernli.

Mernova’s retail cannabis brand ‘Ritual Green’ will be launched and sold through the NSLC’s stores and e-commerce platform while retail sales through other province stores and online platforms may follow.

Ever since the COVID-19 pandemic began, Australian stock market has been experiencing volatility along with a fluctuating trend. However, numerous ASX-listed entities have experienced remarkable growth in their respective share prices, driv...

Creso Pharma Limited’s (ASX:CPH; FRA:1X8) wholly-owned subsidiary, Mernova Medicinal Inc. (Mernova), a Licensed Producer of cannabis products with its operations based in Nova Scotia, Canada, has received an initial purchase order (PO) valu...

Mernova’s retail cannabis brand ‘Ritual Green’ will be launched and sold through the NSLC’s stores and e-commerce platform while retail sales through other province stores and online platforms may follow.